Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Research points to need for new approaches to treatment of high blood pressure

Wake Forest Baptist Medical Center logo.

News provided by

Wake Forest Baptist Medical Center

Dec 10, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX

WINSTON SALEM, N.C., Dec. 10, 2014 /PRNewswire/ -- That blood pressure plays a role in human health has been known for quite a while. Hypertension – the medical term for high blood pressure – was first described as a disease in the early 1800s, and the inflatable cuff that's used in measuring blood pressure was invented in 1896.

That doesn't, however, mean there's nothing new about hypertension, its triggers and its effects. In fact, recent findings have punctured some long-held beliefs about the condition and the best ways to treat it.

Continue Reading
Dr. Carlos M. Ferrario, professor of surgery and founder of the Hypertension and Vascular Research Center at Wake Forest Baptist Medical Center. (Credit: Cameron Dennis / Wake Forest Baptist HealthWire)
Dr. Carlos M. Ferrario, professor of surgery and founder of the Hypertension and Vascular Research Center at Wake Forest Baptist Medical Center. (Credit: Cameron Dennis / Wake Forest Baptist HealthWire)
Hypertension Tips
Hypertension Tips

For example, a study led by Dr. Carlos M. Ferrario, professor of surgery and founder of the Hypertension and Vascular Research Center at Wake Forest Baptist Medical Center in Winston-Salem, N.C., found that there were significant differences in the biological mechanisms that cause high blood pressure in women as compared to men.

"The medical community has thought that high blood pressure was the same for both sexes, and treatment has been based on that premise," said Ferrario, an internationally recognized expert in the field and current president of the Inter-American Society of Hypertension. "Our findings suggest a need to better understand the female sex-specific underpinnings of the hypertensive processes to tailor optimal treatments for this population. We need to evaluate new protocols – what drugs, in what combination and in what dosage – to treat women with high blood pressure."

Another Wake Forest Baptist researcher, Dr. Carlos J. Rodriguez, directed a study of people with hypertension which found that lowering their systolic blood pressure – the first number in a standard reading, as in 140/90 ("140 over 90") – below 120 wasn't necessarily beneficial over the long term.

"Frequently we treat patients' blood pressure to the lowest it will go, thinking that is what's best," said Rodriguez, an associate professor of public health sciences. "But our observational study found that treating to low pressures doesn't significantly reduce the risk of dangerous events like heart attack, heart failure and stroke. This calls into question the common notion that lower is always better."

Blood pressure is simply a measure of how hard blood pushes against the walls of arteries as it moves through the body. It is expressed in two numbers, with the systolic reading (when the heart is pumping) followed by the diastolic reading (between heartbeats). Blood pressure is generally considered normal when it's lower than 120/80 and high when it's 140/90 or above. Readings in between are usually classified as pre-hypertension, which indicates a likelihood of developing high blood pressure.

Hypertension can cause damage to the heart and blood vessels and lead to heart attack, stroke and other serious health problems. Approximately one-third of all American adults have high blood pressure, and the rate is substantially higher among men over 55 and women over 65.

The good news is that high blood pressure is treatable, most commonly by a combination of medicine and lifestyle changes.

But even though it's common, easily identified and controllable, hypertension does have its quirks. In most cases there aren't any symptoms; most people don't find out they have high blood pressure until they go to a doctor for another reason. Because a wide variety of factors can contribute to raised blood pressure – including obesity, diabetes, smoking, drinking too much alcohol, eating too much salt, stress, physical inactivity, kidney disease, having a family history of high blood pressure and aging – and because there are nine categories of anti-hypertension drugs, determining the best course of treatment can be complicated. In fact, most people with hypertension need to take two or more prescription drugs to keep their blood pressure at healthy levels.

It is known that ethnicity can be a factor in the effectiveness of medications – African-Americans, for example, are more responsive to drugs classified as calcium channel blockers than those in the angiotensin inhibitor category – but Ferrario's study clearly indicates that gender should also be a primary consideration in selecting the most appropriate treatment. And while Rodriguez's research findings, which are being put to the test in a large clinical study, suggest that less aggressive therapies may be sufficiently beneficial in treating hypertension, other researchers, including Ferrario, believe that pre-hypertension should be treated more aggressively to delay the occurrence of high blood pressure and thus reduce the risk of cardiovascular damage over time.

Ferrario also advocates that clinical trials should look at long-term morbidity and mortality rates of different medications in addition to the magnitude of blood pressure reduction when weighing the effectiveness of hypertension treatments.

But Ferrario is quick to emphasize that research is not an end in itself.

"In a sense, it's not that we need more research, it's that we need to apply what we know in day-to-day care," he said. "What's the point of doing lots of studies if very little of that is translated into immediate benefits for patients?"

To close what he called an "enormous gap" between what has been learned about hypertension and how it is treated, Ferrario said physicians need to be better educated about research findings so they can make appropriate adjustments to their practice patterns. And patients can contribute, too, by learning what they can do about their condition and being proactive about their care.

"It never hurts," he said, "for a patient to ask a doctor why he or she is recommending a particular treatment or drug."

Photo - http://photos.prnewswire.com/prnh/20141208/163002
Photo - http://photos.prnewswire.com/prnh/20141208/163003-INFO
Logo - http://photos.prnewswire.com/prnh/20111114/DC06171LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-points-to-need-for-new-approaches-to-treatment-of-high-blood-pressure-300006808.html

SOURCE Wake Forest Baptist Medical Center

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.